Bio-Techne Corp
NASDAQ:TECH
Bio-Techne Corp
NASDAQ:TECH
Price:
72.4
USD
-0.15%
Market Closed
Market Cap:
$11.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
Tokio Marine Holdings Inc
F:MH6
|
JP |
|
Universal Music Group NV
F:0VD0
|
NL |
|
C
|
Caterpillar Inc
XMUN:CAT1
|
US |
|
S
|
Star Bulk Carriers Corp
F:4FAP
|
GR |
|
Discovery Ltd
F:D3H0
|
ZA |
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 76.1m | 126.2m | 96.1m | 229.3m | 139.6m | 263.1m | 285.4m | 168.1m | 73.4m | 181.9m | |
| 60m | 64.5m | 78.2m | 82.7m | 87.7m | 101.1m | 107.2m | 111.7m | 109.9m | 97.4m | |
| (3.4m) | (46.7m) | (13.6m) | 13.1m | (27.4m) | 6.8m | (29.6m) | (39.4m) | (51.1m) | 13.2m | |
| 14.6m | 28.2m | 32.3m | 32.4m | 49m | 42.2m | 39.2m | 38m | 40.8m | 41.4m | |
| 26.5m | 24.6m | 48.7m | (114.7m) | 123m | 23.8m | (18.1m) | 68.7m | 143.8m | 41m | |
| 42.9m | 35.1m | 36.8m | 42m | 21m | 30.3m | 88.4m | 65.3m | 74.4m | 64.1m | |
| 7.5m | 9.8m | 21.5m | 18.6m | 13.6m | 11m | 8.4m | 14.5m | 19m | 14.4m | |
| (15.5m) | 1.9m | (27.8m) | (5.2m) | 29.3m | (69.5m) | (90.6m) | (10.1m) | 11.5m | (41.3m) | |
| 143.7m | 170.4m | 181.6m | 205.2m | 352.2m | 325.3m | 254.4m | 299m | 287.6m | 292.1m | |
| (15.2m) | (20.9m) | (25.4m) | (51.7m) | (44.3m) | (44.9m) | (38.2m) | (62.9m) | (31m) | (28.9m) | |
| (290.8m) | (17.8m) | (311.4m) | 78.8m | (199.2m) | (51.9m) | (227.4m) | (140.2m) | (4.2m) | 10.7m | |
| (306m) | (38.7m) | (336.8m) | 27.1m | (243.5m) | (96.9m) | (265.6m) | (203m) | (35.2m) | (18.2m) | |
| 5.3m | 19.2m | 22.5m | 20.9m | 21.9m | (83.8m) | 10.3m | (19.1m) | (224m) | 38.9m | |
| 252m | (4.5m) | 166.5m | (148.5m) | (15.5m) | (85.5m) | 94m | (31m) | 27m | (146m) | |
| (47.3m) | (48m) | (48.4m) | (48.9m) | (49.6m) | (50.2m) | (50.3m) | (50.4m) | (50.4m) | (49.9m) | |
| (20.8m) | (65.9m) | (6.3m) | (7.3m) | (19.3m) | (23.4m) | (31.4m) | (21.9m) | (6.5m) | (12.1m) | |
| 189.1m | (99.2m) | 134.4m | (183.8m) | (62.6m) | (242.9m) | 22.6m | (122.4m) | (253.9m) | (169.1m) | |
| 500k | (2.1m) | (300k) | (2.8m) | 6.4m | (12.1m) | (3.4m) | (2.3m) | 11.9m | (2.2m) | |
| 27.3m | 30.4m | (21.1m) | 45.7m | 52.5m | (26.6m) | 8m | (28.8m) | 10.4m | 102.5m | |
| 128.5m | 149.5m | 156.2m | 153.5m | 307.9m | 280.4m | 216.2m | 236.1m | 256.6m | 263.2m |
A growing diagnostics platform with improving margins and uneven cash conversion
A high-margin precision-instrument franchise with durable cash generation and substantial buybacks
A mature genomics platform rebuilding growth while preserving cash generation
Acquisition-expanded revenue base with temporarily compressed earnings and cash conversion
Continue TECH Research
Other Bio-Techne Corp listings: